Vice Chairman of the Board of Directors
BB Biotech AG
United States Minor Outlying Islands
Dr. Clive A. Meanwell, Ph.D., has been Vice Chairman of the Board of Directors at BB Biotech Inc. since 2011. Previously, he was Member of the Board of Directors from 2004. He is Member of the Audit Committee and Chairman of the Remuneration and Nomination Committee at the Company. He is Member of the Board of Directors and Chief Executive Officer of The Medicines Company, which he established in 1996. From 1995 to 1996 he was a founding partner and managing director of MPM Capital L.P., one of the world’s largest dedicated investors in life sciences. He previously held various positions at Hoffmann-La Roche in Basel and Palo Alto, California. His responsibilities included Worldwide Drug Regulatory Affair, clinical leader of product development as well as the launch of Roche/Amgen’s Neupogen. Dr. Meanwell received his M.D. and Ph.D. from the University of Birmingham in the UK where he also trained in medical oncology.